Trial Profile
A Multicenter, Randomized, Double Blind Study to Compare the Efficacy Between Cilostazol and Aspirin on White Matter Changes by Cerebral Small Vessel Disease
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Aug 2021
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary) ; Aspirin
- Indications Thrombotic microangiopathy
- Focus Therapeutic Use
- Acronyms Challenge
- 06 Aug 2019 Planned End Date changed from 1 Oct 2018 to 31 Aug 2019.
- 23 Sep 2016 Planned End Date changed from 1 Feb 2016 to 1 Oct 2018.
- 23 Sep 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Aug 2018.